| 注册
首页|期刊导航|中国实验方剂学杂志|通脑饮通过PI3K/Akt/GSK-3β信号通路促进血管新生改善脑缺血损伤

通脑饮通过PI3K/Akt/GSK-3β信号通路促进血管新生改善脑缺血损伤

刘燕 李文磊 吴明华 吴洋 彭婉慧 陈婧怡 甘佳乐 厉励 夏杨静怡 李昀泽 陈兆耀

中国实验方剂学杂志2026,Vol.32Issue(9):100-110,11.
中国实验方剂学杂志2026,Vol.32Issue(9):100-110,11.DOI:10.13422/j.cnki.syfjx.20251937

通脑饮通过PI3K/Akt/GSK-3β信号通路促进血管新生改善脑缺血损伤

Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway

刘燕 1李文磊 1吴明华 1吴洋 1彭婉慧 2陈婧怡 1甘佳乐 1厉励 1夏杨静怡 1李昀泽 1陈兆耀1

作者信息

  • 1. 南京中医药大学 附属医院/江苏省中医院/南京中医药大学 第一临床医学院,南京 210029
  • 2. 南京中医药大学 附属医院/江苏省中医院/南京中医药大学 第一临床医学院,南京 210029||南京江北医院,南京 210044
  • 折叠

摘要

Abstract

Objective:To investigate the mechanisms of Tongnao decoction(TND)in mice with acute ischemic stroke(AIS).Methods:Fifty male C57BL/6J mice were randomly divided into a sham operation group,model group,TND low-dose group(1.86 g·kg-1),TND high-dose group(3.72 g·kg-1),and butylphthalide(NBP)group(10 mg·kg-1),with 10 mice in each group.A mouse model of cerebral ischemic injury was established using photochemical thrombosis(PT).The sham operation group and model group were administered an equal volume of normal saline by gavage.All five groups were treated once daily for 14 consecutive days.Behavioral tests were performed before modeling and at the end of administration.T2-weighted imaging(T2WI)was performed 3 days after modeling to evaluate the extent of injury.Hematoxylin-eosin(HE)staining was used to observe histological changes in the cerebral cortex,and Nissl staining was used to observe neuronal morphology.Cerebral blood flow in mice was detected using a laser speckle contrast imaging(LSCI)system.Immunofluorescence staining was used to detect the cell proliferation marker bromodeoxyuridine(BrdU)and the highly glycosylated type I transmembrane glycoprotein CD34.Western blot analysis was used to detect the expression levels of phosphatidylinositol 3-kinase(PI3K),protein kinase B(Akt),glycogen synthase kinase-3β(GSK-3β),and their phosphorylation levels,as well as tight junction-related proteins zonula occludens-1(ZO-1),Occludin,and Claudin-5 in the peri-infarct tissue.Thirty-five zebrafish were randomly divided into normal control group,model group,TND low and high dose groups(0.16,0.32 g·L-1)and NBP group(10 μmol·L-1),with 7 in each group.A stereoscopic fluorescence microscope was used to observe vascular growth in zebrafish.Results:Imaging showed that PT caused ischemia in the right cortical region.Behavioral tests indicated that,compared with the model group,the drug-treated groups reduced the error rate of irregular balance ladder climbing on the affected side and shortened the tape removal time(P<0.05).HE staining and Nissl staining showed that,compared with the model group,the drug-treated groups exhibited reduced brain tissue damage,fewer scars,and improved neuronal morphology.LSCI results showed that the drug-treated groups partially restored cerebral blood perfusion and promoted the establishment of collateral circulation compared with the model group.Immunofluorescence staining indicated that the drug-treated groups increased the positive rates of BrdU and CD34 compared with the model group(P<0.01),promoting angiogenesis.Meanwhile,compared with the model group,the drug-treated groups upregulated the expression levels of p-PI3K,p-Akt,p-GSK-3β,and tight junction proteins ZO-1,Occludin,and Claudin-5(P<0.05,P<0.01),and increased the number of intersegmental vessels in zebrafish(P<0.05,P<0.01).Conclusion:TND can promote angiogenesis around the infarct in PT model mice by regulating the PI3K/Akt/GSK-3β signaling pathway,thereby improving cerebral ischemic injury.

关键词

通脑饮/急性缺血性脑卒中/神经功能恢复/磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)/糖原合成酶激酶-3β(GSK-3β)/光化学栓塞法

Key words

Tongnao decoction/acute ischemic stroke/neurofunctional recovery/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/glycogen synthase kinase-3β(GSK-3β)/photothrombosis

分类

医药卫生

引用本文复制引用

刘燕,李文磊,吴明华,吴洋,彭婉慧,陈婧怡,甘佳乐,厉励,夏杨静怡,李昀泽,陈兆耀..通脑饮通过PI3K/Akt/GSK-3β信号通路促进血管新生改善脑缺血损伤[J].中国实验方剂学杂志,2026,32(9):100-110,11.

基金项目

国家自然科学基金面上项目(82474435,82274428) (82474435,82274428)

江苏省自然科学基金面上项目(BK20241996) (BK20241996)

江苏省中医药管理局项目(ZT202102) (ZT202102)

江苏省卫健委医学科研重点项目(K2023009),江苏省研究生实践创新计划项目(SJCX24_0952,SJCX25_0999) (K2023009)

中国实验方剂学杂志

1005-9903

访问量0
|
下载量0
段落导航相关论文